Exploring the optimal sequence of abiraterone and enzalutamide in patients with chemotherapy-naive castration-resistant prostate cancer: The Kyoto-Baltimore collaboration - Terada, N; Maughan, B L; Akamatsu, S (Int J Urol, 2017)
et al.